首页> Lung cancer (Amsterdam, Netherlands)> Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.

Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.

导出 LinkOut

翻译打印收藏纠错

第一作者： B,Abbar

第一单位： Department of Thoracic Oncology, Bichat-Claude Bernard Hospital, AP-HP, Sorbonne University, Paris, France.

作者： B,Abbar ^[1] ; V,De Castelbajac ^[2] ; P,Gougis ^[3] ; S,Assoun ^[4] ; J,Pluvy ^[4] ; C,Tesmoingt ^[5] ; N,Théou-Anton ^[6] ; A,Cazes ^[7] ; C,Namour ^[4] ; A,Khalil ^[8] ; V,Gounant ^[4] ; B,Besse ^[9] ; G,Zalcman ^[10] ; S,Brosseau ^[4]

作者单位： Department of Thoracic Oncology, Bichat-Claude Bernard Hospital, AP-HP, Sorbonne University, Paris, France. ^[1] Breast Disease Center, Saint Louis Hospital, AP-HP, Université de Paris, Paris, France. ^[2] Department of Pharmacology, Department of Medical Oncology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, INSERM, CIC-1901 Paris-Est, CLIP(2)Galilée, Paris, France. ^[3] Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France. ^[4] Department of Clinical Pharmacy, Bichat-Claude Bernard Hospital, AP-HP, Paris, France. ^[5] Department of Genetics, Bichat-Claude Bernard Hospital, AP-HP, Paris, France. ^[6] Department of Pathology, Bichat-Claude Bernard Hospital, Université de Paris, AP-HP, Paris, France. ^[7] Department of Radiology, University Hospital Bichat-Claude Bernard, AP-HP, Paris, France. ^[8] Department of Cancer Medicine, Institut Gustave Roussy, Saclay University Villejuif, France. ^[9] Department of Thoracic Oncology, CIC 1425 INSERM, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France. Electronic address: gerard.zalcman@aphp.fr. ^[10]

关键词 Cytotoxic T-lymphocyte-associated protein 4 antigen Hyperprogressive disease Immunotherapy Non-small-cell lung cancer Programmed cell death 1 ligand 2 protein Programmed cell death 1 receptor

医学主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);肺肿瘤(Lung Neoplasms);回顾性研究(Retrospective Studies)

DOI 10.1016/j.lungcan.2020.12.026

PMID 33385736

发布时间 2021-06-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交